Lobular carcinoma in situ of unspecified breast
ICD-10 D05.00 is a billable code used to indicate a diagnosis of lobular carcinoma in situ of unspecified breast.
Lobular carcinoma in situ (LCIS) of the breast is a non-invasive form of breast cancer characterized by the abnormal growth of lobular cells within the breast lobules. Unlike invasive breast cancer, LCIS does not invade surrounding breast tissue, making it a marker of increased risk for developing invasive breast cancer in either breast later in life. Patients with LCIS often present with no symptoms, and it is typically discovered incidentally during a biopsy performed for another reason. The diagnosis is confirmed through histopathological examination, which reveals the presence of atypical lobular cells. Although LCIS is not classified as breast cancer in the traditional sense, it is considered a significant risk factor, prompting close surveillance and management strategies. Patients diagnosed with LCIS are often advised to undergo regular mammograms and may be considered for additional imaging or preventive measures, such as chemoprevention or prophylactic mastectomy, depending on individual risk factors and patient preferences. Understanding the nuances of LCIS is crucial for effective patient management and risk assessment.
Detailed pathology reports, treatment plans, and follow-up care notes.
Patients diagnosed with LCIS undergoing surveillance or risk-reducing surgeries.
Ensure accurate coding of any concurrent conditions or treatments that may affect management.
Clear imaging reports and indications for follow-up imaging.
Imaging studies performed for patients with a history of LCIS.
Document the rationale for imaging frequency and any findings that may alter management.
Used when a biopsy is performed to confirm the diagnosis of LCIS.
Pathology report detailing the findings of the biopsy.
Oncologists should ensure that the pathology report is comprehensive and includes all relevant findings.
Lobular carcinoma in situ (LCIS) is a non-invasive breast condition where abnormal cells are found in the lobules of the breast. It is not considered breast cancer but indicates an increased risk for developing invasive breast cancer.
